An evaluation of the efficacy and safety of doxazosin in hypertension associated with renal dysfunction
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (1) , 381-388
- https://doi.org/10.1016/0002-8703(91)90876-j
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacokinetic and pharmacological properties of doxazosin mesilate in Japanese healthy adult volunteers.Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1988
- Hemodynamic effects of tilisolol, a new .BETA.-adrenergic blocking agent with vasodilating property, and doxazosin, a new .ALPHA.-adrenergic blocking agent, in essential hypertension.Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1988
- Pharmacokinetics and effect on blood pressure of doxazosin in normal subjects and patients with renal failureClinical Pharmacology & Therapeutics, 1986
- The antihypertensive effects of doxazosin: a clinical overview.British Journal of Clinical Pharmacology, 1986
- Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.British Journal of Clinical Pharmacology, 1986
- Acute renal effects of doxazosin in man.Published by Wiley ,1986
- Clinical pharmacological studies with doxazosin.British Journal of Clinical Pharmacology, 1986
- The metabolism and kinetics of doxazosin in man, mouse, rat and dog.British Journal of Clinical Pharmacology, 1986
- The alpha 1‐adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.British Journal of Clinical Pharmacology, 1986